Diagnostic Preparedness Platform WHO R&D Blueprint for Priority Infectious Diseases with Epidemic Potential
|
|
- Annabel Stewart
- 6 years ago
- Views:
Transcription
1 Diagnostic Preparedness Platform WHO R&D Blueprint for Priority Infectious Diseases with Epidemic Potential 2 nd round presentation Geneva July 21 st, 2016
2 Diagnostic Preparedness Platform Aim Surveillance and monitoring of pathogens with high epidemic potential in resource limited settings Capacities for fast ramp up of diagnostic testing in central lab settings of epicentres of an outbreak and at the point of need Strategy Early detection of onsets of outbreaks by diagnostic tools in decentralized settings Corresponding central lab based confirmatory tests Scalability of production and implementation of POC and central lab based tests by leveraging existing R&D and production capacities at Alere and altona Capacity building and training in epidemiological hot spots 2
3 Diagnostic Preparedness Platform 3
4 MH2 Diagnostic Preparedness Platform Alere Technologies Alere q and lateral flow POC system Proven applicability Decentralized testing Scalable in volume and number of assays CE IVD, WHO PQ Dxfor Alere q HIV1/2 Detect Proven compatibility between altona RealStar assays and Alere q Filovirus Detect altona Diagnostics RealStar product line for tropical infectious disease Proven high quality standardized real-time (RT)-PCR kits CE IVD, FDA EUA, WHO EUAL Proven fast response to outbreaks (SARS, MERS, flu, CHIKV, EBOV, ZIKV) AltoStarautomatedhigh thoughput central lab workflow Solution Extension of Alere q assay portfolio by tests for WHO listed pathogens Extension of existing RealStar real-time PCR assay portfolio to complete high priority list transfer to the AltoStar automated workflow Creation of a scientific network of reference laboratories on a global scale 4
5 Folie 4 MH2 I would make two slides out of this one Markus Hess;
6 Alere q Technology Multiple Assays add sample direct from patient Molecular POC Array based detection Connected Automatic: Extraction Purification, Amplification and detection Single use Cartridge Onboard device and assay controls 5
7 Alere q Cartridge Features No cold chain requirements Real multiplexing capabilities Enables for diagnostic test panels SNP Detection Integrated Cartridge Workflow Extraction Target Isolation Amplification Array Detection - Chemical lysis - Mechanical lysis -Heat lysis - Specific target capturing (e.g. RNA) using biotinylated probes on sepharose beads PCR Real time & end point, Melting curves CMA technology; high density arrays - Unspecific DNA binding on silica beads 6
8 altona RealStar Technology Laboratory high throughput altona RealStar / AltoStar RealStar: Open platform Application on commonly used real-time PCR instruments High throughput in centralised laboratories Flexible parallel testing for target organism and differential diagnostic Parallel testing of symptomatically similar pathogens: shared PCR profile, shared internal control AltoStar workflow: Automated NA extraction from different sample matrices and automated PCR set-up MH7 7
9 Folie 7 MH7 Automated NA extraction from different sample matrices and automated PCR set-up Markus Hess;
10 SD Bioline Ab RDT s Product Specification Sample Type : serum, plasma and whole blood Sample Volume : 10 ul Interpretation Time : min Nitrocellulose membrane Control line Gold Conjugate Pad Sample Pad Absorbent pad Test procedure Test line (1) Dispense 10 ul of specimen into the sample well(s). SD Color scale chart (2) Dispense 4 drops of assay diluent vertically into the assay diluent well. (3) Interpret test results in 15~20 minutes. *Score rating 1+ positive: G1~G8 2+ positive: G9~G14 3+ positive: G15~G20 8
11 DPP Assay Panels Assay panels for Nucleic Acid Testing 1. VHF panelmandatorily including Ebola and Marburg viruses, Lassa virus, Rift Valley fever virus, and CCHF virus Optionally: Zika virus, dengue virus, and chikungunya virus, as well as malaria 2. Respiratory panel, mandatorily including SARS-CoV, MERS-CoV Optionally: pandemic Influenza viruses, RSV, MPV, PIV 3. Encephalitis panel, mandatorily including Nipah virus Optionally: Japanese encephalitis virus, Enterovirus species, rabies virus, herpesviruses and measles virus The lateral flow assays: Malaria and dengue on market Zika and chikungunya IgM/IgG/Ag in development. Other LF tests will be evaluated case by case to ensure appropriate use of RDT s within their performance specifications. 9
12 DPP Assay Panels Assay strategy POC assays to be spatially multiplexed in a multianalyte cartridge covering clinically relevant pathogens Central lab assays to be designed to run in parallel using one sample preparation offering flexibility to include region specific pathogens in the panel testing Shared process controls for QC and proficiency testing Selected lateral flow assays to widen the diagnostic window 10
13 Platform Integration Pathway I Transfer of existingrealstar assays to multiplexed Alere q POC system Example: Filovirus CCHFV Rift Valley fever virus Advantage: Same controls and uniform post-market-surveillance, relatively low development risk 11
14 Platform Integration Pathway II In case of new pathogens or new genotype parallel development of lab based and POC system. Advantage: Faster availability of outbreak control measures on all levels. 12
15 DPP Advantages Validation Shared validation protocols for Alere q and RealStar assays Leveraging biobanks, strain collections and BLS4 capacities of existing network of reference laboratories for validation of panels with stored samples and viral cultures Employment of developed panels in reference labs and their outstations for usability testing Laboratory Collaboration Network (LCN) Production and Quality Control Utilisation of existing production capacities for Alere q cartridges, lateral flow assays and RealStar/AltoStar assays Establishment of quality control process for panels 13
16 altona s Capacity Supply Fast ramp up of production capacity Own oligonucleotide production Own enzyme production Independence of suppliers for main components Example of ramp up potential: Filovirus assay 14
17 altona Portfolio and Pipeline Panel Assay planed development verification validation launched regulatory status Respiratory SARS CoV CE-IVD MERS CoV CE-IVD, FDA EUA Influenza A/B virus CE-IVD Respiratory syncytial virus CE-IVD Parainfluenza virus CE-IVD Human metapneumovirus CE-IVD VHF Filoviridae CE-IVD, WHO EUAL, FDA EUA Lassa virus CCHF virus Rift Valley fever virus Malaria parasites Dengue virus Chikungunya virus Zika virus Hantavirus Yellow fever virus CE-IVD Research Use Only CE-IVD CE-IVD CE-IVD CE-IVD, WHO EUAL*, FDA EUA Encephalitis Nipah virus Japanese encephalitis virus West Nile virus Herpes simplex virus Varizella zoster virus Measles virus CE-IVD CE-IVD CE-IVD * submitted 15
18 Alere s Global Capability Leading global supplier of POC diagnostics Shipped over 1 billion tests in 2015 Highly automated, high throughput and scalable manufacturing across sites in NA, Asia and Europe encompassing both lateral flow and instrument-based POC assays ~1/3 of our business is in Infectious Diseases and this is spread very evenly between regions (Sub-Saharan Africa, Latin America, Asia Pacific, Europe and the Middle East and North America) Our global reach * Regional Distributors: 147 Regional Distributors : 124 Regional Distributors: ** * 113 Key: Commercial T. Support Manufacturing R&D * Excludes Contracted Workers (3582) ** Excludes Philippines Health Management Business (939) 16
19 Alere q Assay Portfolio Alere q HIV-1/2 Detect Qualitative HIV diagnosis test for whole blood and plasma samples (CE-IVD marked, WHO PQ review) Alere q Filovirus Detect Pan-Filovirusscreening assay panel for detection and discrimination of 6 known Ebola and Marburg virus species (in clinical validation) FILOatj01 SUDV FILOatj02 EBOV FILOatj03 BDBV FILOatj04 TAFV FILOatj05 MARV FILOatj06 RESTV Alere q HIV-1/2 VL Plasma Quantitative HIV monitoring test for plasma samples (in development) Alere q Carba Profile Qualitative test for the detection of 11 clinically most relevant carbapenemase genes from swab samples (in feasibility) other applications MRSA profile, Respiratory Panel, Fever Panel, STI Panel, Companion Diagnostics 17
20 Alere SD WHO Prequalified Product Pipeline Completed 7 Under progress 2 In development 18
21 Data Management and Epidemiology Incidence Tracking Geographic Mapping
22 The MOFINA Project Showcase The goals: Develop, validate and deploy a fully integrated, POC, molecular pan- Filovirus assay The project: Mobile Filovirus Nucleic Acid Test (MOFINA) The consortium: Technical/development: Alere Technologies and altona Diagnostics Evaluation/validation: BNITM, INMI Lazzaro Spallanzani, PHE, FIND The approach: Integrate widely used, CE-IVD, FDA EUA, WHO EUAL RealStar Filovirus assay with the Alere q analyzer and cartridge technology incorporating fully-integrated sample preparation, target amplification and detection The Status: Field validation in Sierra Leone, FDA EUA pre-submission complete With support from
23 The MOFINA Project Showcase The only POC Pan-Filovirusassay which detects and discriminatesall known Ebola species and detects both known Marburg species In-field (Sierra Leone) clinical testing completed with 69 samples FDA EUA pre-submission completed, WHO EUAL in process CE IVD submission in 2016 Product Development Validation & Clinical Support -MOFINA partners Molecular POC Multiplex Screen 6 Species in a Single Test FILOatj01 SUDV FILOatj02 EBOV FILOatj03 BDBV FILOatj04 TAFV FILOatj05 MARV FILOatj06 MARV Ravn FILOatj07 RESTV 21
24 The MOFINA Project Showcase The partnership Alere Technologies (an Alere Inc. company) altona Diagnostics Bernhard Nocht Institute for Tropical Medicine (BNITM) Istituto Nazionale Malatie Infettie(INMI) Lazzaro Spallanzani Public Health England Porton Down The Foundation for Innovative New Diagnostics (FIND) Assay development Led by Alereand altona based on existing technology (Alereq platform, altona Filovirus assay) Design inputs from all project partners Assay validation Some work in house with purified nucleic acids Live cultured virus by BNITM, INMI and PHE in BSL4 facilities Retained patient sample testing in Sierra Leone facilitated by FIND and PHE With support from
25 Laboratory Collaboration Network The strategy Partner with national and international scientific institutions Global footprint to cover genetic background, environmental and ethnical diversity Inclusion of most of the variety of strains and subspecies of the focal pathogens The management co-managed by Alere and altona The role Definition of design input, user specifications, product profiles Prototype testing, verification and validation, field data Focal points for piloting the deployment of technologies, training and pilot monitoring and surveillance programs
26 Laboratory Collaboration Network Currently existing laboratory network(to be extended) Bernhard-NochtInstitute for Tropical Medicine WORLD MAP to be added Which ones do we have?
27 DPP project structure
28 DPP project plan 1 Viral Hemorrhagic Fever Panel 1.1 Development Year 1 Year 2 Year 3 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 RUO RUO RUO 1.2 Verification 1.3 Validation 1.4 Technical documentation CE-IVD CE-IVD CE-IVD 1.5 deployment 2 Respiratory Panel RUO RUO RUO 3 Encephalitis panel RUO RUO RUO 4 process control panels 4.1 Development 4.4 Technical documentation * single target assay RealStar/ Altostar Alere q SD Bioline*
29 DPP Development Estimates Development cost and timelines Estimated 15,9 Mio. USD 3 years development and deployment project VHF panel CE IVD marked, respiratory and encephalitis panel RUO Duration of validation phase is highly dependent on access to isolates and specimens, Regulatory Authority requirements, appropriate ethical approval(s), logistics and financing. Deployment, training and field studies on VHF in several geographically distributed areas 27
30 Key DPP Development Challenges Access to isolates and clinical specimens Despite intentions by stakeholders to establish repositories and banks access to pathogen isolates and clinical specimens remains a major challenge for product developers Sustainability Lack of current business case for potential assay makes justifying R&D spend and occupying precious R&D time very difficult Support in form of external financing of R&D and/or assay volume guarantees need to be explored Develop and supply critical products Industry Implementers, multilaterals, academics Design inputs, surveillance information, samples and isolates 28
Selection and use of Ebola in vitro diagnostic (IVD) assays
EMERGENCY GUIDANCE Selection and use of Ebola in vitro diagnostic (IVD) assays June 2015 World Health Organization 2015. All rights reserved. The designations employed and the presentation of the material
More informationFirms and Federal Labs Flock to Seek FDA Emergency Use Authorization for Ebola MDx Assays
Firms and Federal Labs Flock to Seek FDA Emergency Use Authorization for Ebola MDx Assays October 21, 2014 Firms and Federal Labs Flock to Seek FDA Emergency Use Authorization for Ebola MDx Assays By Madeleine
More informationSurveillance strategy during Phase 3 of the Ebola response
EMERGENCY GUIDANCE Surveillance strategy during Phase 3 of the Ebola response 5 November 2015 World Health Organization 2015. All rights reserved. The designations employed and the presentation of the
More informationSURVEILLANCE AND LABORATORY DIAGNOSTICS OF INFECTIOUS DISEASES IN THE RUSSIAN FEDERATION I. DYATLOV
SURVEILLANCE AND LABORATORY DIAGNOSTICS OF INFECTIOUS DISEASES IN THE RUSSIAN FEDERATION FEDERAL SERVICE OF SURVAILLANCE IN THE FIELD OF CONSUMER RIGHT PROTECTION & HUMAN WELFARE, RUSSIA I. DYATLOV Russia
More informationQuantStudio Dx Real-Time PCR Instrument
QuantStudio Dx Real-Time PCR Instrument Behind every diagnosis, there is a promise You believe in molecular medicine. So do we. We are committed to providing you with comprehensive solutions that help
More informationAlere q. A platform to answer global health needs: TB and beyond. Duncan Blair Director, Public Health Initiatives
Alere q A platform to answer global health needs: TB and beyond Duncan Blair Director, Public Health Initiatives 7 th FIND Symposium, Barcelona, October 2014 Alere q platform overview Comprising the Alere
More informationChoose only what you really need
The LightMix Modular Assays Choose only what you really need PICK CREATE RUN The LightMix Modular Assays ONE simple concept, THREE big benefits Easy to Use Select from a huge range of ready-to-use individual
More informationFirst Annual Biomarker Symposium Quest Diagnostics Clinical Trials
First Annual Biomarker Symposium Quest Diagnostics Clinical Trials Terry Robins, Ph.D. Director Biomarker R&D and Scientific Affairs Quest Diagnostics Clinical Trials Key Considerations: Biomarker Development
More informationKessler: Molecular Diagnostics of Viruses Relevant in the Immunocompromised Patient. Wien, November 2012
MOLECULAR DIAGNOSTICS OF VIRUSES RELEVANT IN THE IMMUNOCOMPROMISED PATIENT VIRUSES RELEVANT IN THE IMMUNOCOMPROMISED PATIENT EBV HHV6 (HHV7) (HHV8) HSV1 HSV2 Parvovirus B19 Polyomavirus BK (Polyomavirus
More informationMolecular methods in medical microbiology: Current and future trends
Bangladesh Journal of Medical Science Vol.10 No.3 Jul 11 Editorial Introduction Molecular methods in medical microbiology: Current and future trends Microbial diseases are the principal causes of morbidity
More informationDeveloping an Accurate and Precise Companion Diagnostic Assay for Targeted Therapies in DLBCL
Developing an Accurate and Precise Companion Diagnostic Assay for Targeted Therapies in DLBCL James Storhoff, Ph.D. Senior Manager, Diagnostic Test Development World Cdx, Boston, Sep. 10th Molecules That
More informationIsolation of Viral RNA, Viral DNA and Bacterial DNA from Animal Samples
Application Note Isolation of Viral RNA, Viral DNA and Bacterial DNA from Animal Samples Denis Flüge, Lillian Krüger, Sandy Leifholz and Holger Engel R&D Department, QIAGEN GmbH, QIAGEN Straße 1, Hilden,
More informationGuidance on Request for Information on Rapid Response Platform Technologies for Epidemic Preparedness
Guidance on Request for Information on Rapid Response Platform Technologies for Epidemic Preparedness Purpose of this request for information The Bill & Melinda Gates Foundation (BMGF; also referred to
More informationNew Biological Reference Materials in 2015 Updated January 2016
New Biological Reference Materials in 2015 Updated January 2016 Part Number Part Description/ Intended use INTERNATIONAL STANDARDS AND REFERENCE PREPARATIONS 13/172 Lupus Anticoagulant (1st International
More informationUNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES
UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES Biodefense solutions to protect our nation Forward genomic surveillance advances DoD biomedical research toward combating high-consequence
More informationInstructions for Use. RealStar Lassa Virus RT-PCR Kit /2017 EN
Instructions for Use RealStar Lassa Virus RT-PCR Kit 1.0 04/2017 EN RealStar Lassa Virus RT-PCR Kit 1.0 For research use only! (RUO) 641003 INS-641000-EN-S01 96 04 2017 altona Diagnostics GmbH Mörkenstr.
More informationPositioning of TB Diagnostics within a Tiered System Integrated Approach from Reference to District Laboratory. Giorgio Roscigno CEO FIND
Positioning of TB Diagnostics within a Tiered System Integrated Approach from Reference to District Laboratory Giorgio Roscigno CEO FIND Integrated Laboratory Network Definition An integrated laboratory
More informationHigh Cross-Platform Genotyping Concordance of Axiom High-Density Microarrays and Eureka Low-Density Targeted NGS Assays
High Cross-Platform Genotyping Concordance of Axiom High-Density Microarrays and Eureka Low-Density Targeted NGS Assays Ali Pirani and Mohini A Patil ISAG July 2017 The world leader in serving science
More informationPrimerdesign TM Ltd. Dengue, Chikungunya, Zika Virus. (Multiplex kit) genesig kit. 100 tests. For general laboratory and research use only
Primerdesign TM Ltd Dengue, Chikungunya, Zika Virus (Multiplex kit) genesig kit 100 tests For general laboratory and research use only Introduction to Flaviviruses Flavivirus is a genus of viruses in the
More informationPublic private partnerships
THE INTERNATIONAL CONFERENCE ON (RE-)EMERGING INFECTIOUS DISEASES 14 March 2018 in Addis Ababa, Ethiopia Public private partnerships Engaging the private research sector to scale up infectious diseases
More informationAuthorizations of Emergency Use of In Vitro Diagnostic Devices for Detection of Zika Virus;
This document is scheduled to be published in the Federal Register on 06/17/2016 and available online at http://federalregister.gov/a/2016-14380, and on FDsys.gov 4164-01-P DEPARTMENT OF HEALTH AND HUMAN
More informationGENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE)
TriMark Publications April 2007 Volume: TMRGER07-0401 GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS
More informationRapid Diagnostic Tests in malaria case management
Rapid Diagnostic Tests in malaria case management Planning, Procuring and Implementing Suggestions for incorporation of malaria RDT-based diagnosis into proposals to the Global Fund Foundation for Innovative
More informationPerformance Efficient Extraction of Viral DNA and RNA from a Variety of Human Sample Materials
MagNA Pure System Application Note No. 1 March 2015 Performance Efficient Extraction of Viral DNA and RNA from a Variety of Human Sample Materials using a Single Standardized Protocol with the MagNA Pure
More informationAdvances in Medical Microbiology - Are the Patients Better Off?
Advances in Medical Microbiology - Are the Patients Better Off? R.P. Rennie Professor Emeritus. Laboratory Medicine and Pathology University of Alberta. Clinical Microbiology Consultant Alberta Health
More informationInterim Technical Note The Use of Cholera Rapid Diagnostic Tests November 2016
Objective Interim Technical Note The Use of Cholera Rapid Diagnostic Tests November 2016 To provide interim guidance to Ministries of Health and other organizations on the potential use of commercially
More informationZika Virus. genesig Advanced Kit. Polyprotein gene. 150 tests. Primerdesign Ltd. For general laboratory and research use only
TM Primerdesign Ltd Zika Virus Polyprotein gene genesig Advanced Kit 150 tests For general laboratory and research use only 1 Introduction to Zika Virus Zika virus (ZIKV) is a member of the Flaviviridae
More informationEbola Zaire Real-TM Handbook
For Professional Use Only Ebola Zaire Real-TM Handbook Real-Time PCR test for qualitative detection of Ebola Virus 100 REF V69-100FRT NAME Ebola Zaire Real-TM INTRODUCTION Ebola virus (EBOV, formerly designated
More informationClinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation
Design Clinical validation trial of a diagnostic for Ebola Zaire antigen detection: Design rationale and challenges to implementation CLINICAL TRIALS Clinical Trials 2016, Vol. 13(1) 66 72 Ó The Author(s)
More informationZIKAVAX PARTNERSHIP. Dr Odile LEROY DCVMN Seoul 26 th September 2017
ZIKAVAX PARTNERSHIP Dr Odile LEROY DCVMN Seoul 26 th September 2017 1 Product Development Partnership THE EUROPEAN VACCINE INITIATIVE IS A PRODUC T DEVELOPMENT PARTNERSHIP WHICH AIMS TO ACCELERATE THE
More informationWHO Prequalification of In Vitro Diagnostics Programme Amended PUBLIC REPORT
WHO Prequalification of In Vitro Diagnostics Programme Amended PUBLIC REPORT Product: SD BIOLINE Malaria Ag P.f/Pan and SD BIOLINE Malaria Ag P.f/Pan POCT PQDx Reference Number: PQDx 0030-012-01 Abstract
More informationi) Wild animals: Those animals that do not live under human supervision or control and do not have their phenotype selected by humans.
The OIE Validation Recommendations provide detailed information and examples in support of the OIE Validation Standard that is published as Chapter 1.1.6 of the Terrestrial Manual, or Chapter 1.1.2 of
More informationSAMPLE PROCEDURE , 11/07
SAMPLE PROCEDURE This Sample Procedure is not intended as a substitute for your facility s Procedure Manual or reagent labeling, but rather as a model for your use in customizing for your laboratory s
More information1. APPROVED MALARIA RDTS
1. APPROVED MALARIA RDTS There are many different Rapid Diagnostic Tests available in the market. To assist partners of the Three Diseases Fund in the selection of the appropriate RDT, the Fund Manager
More informationInstructions for Use. RealStar Zika Virus RT-PCR Kit /2017 EN
Instructions for Use RealStar Zika Virus RT-PCR Kit 1.0 01/2017 EN RealStar Zika Virus RT-PCR Kit 1.0 For use with Mx 3005P QPCR System (Stratagene) VERSANT kpcr Molecular System AD (Siemens Healthcare)
More informationClassification under the IVD Regulation
Classification under the IVD Regulation Nick Baker Head of IVD Notified Body LRQA Ltd Improving performance, reducing risk IVD regulation shift in regulatory scrutiny Under the current IVD directive 10-15%
More informationAmpliSens VZV-FRT. PCR kit. Instruction Manual. For Professional Use Only
For Professional Use Only AmpliSens VZV-FRT PCR kit Instruction Manual AmpliSens Ecoli s.r.o., Studenohorska 12 841 03 Bratislava 47 Slovak Republic Tel.: +421 2 6478 9336 Fax: +421 2 6478 9040 Federal
More informationInstrument specifications Technology Software Host interfaces Printer interfaces Data Station Physical dimensions Weight Certifications
The evolution of PCR Introducing the COBAS TaqMan 48 Analyzer At the forefront of PCR evolution Since Roche acquired the rights to PCR in 1991, its mission has been to fully realize the potential of this
More informationFast decisions instead of delays Quality Control through outstanding design
Fast decisions instead of delays Quality Control through outstanding design We are CustomBiotech from Roche In your operations, behind your decisions, powering your products You are driving a paradigm
More informationHELINI White spot Syndrome virus [WSSV] Real-time PCR Kit
HELINI White spot Syndrome virus [WSSV] Real-time PCR Kit Instruction manual Cat. No: 6001-25/50/100 tests Compatible with: Agilent, Bio-Rad, Roche, Applied Bio systems [ABI], Rotor-gene, Cepheid, Bioer,
More informationDiagnostics gathering intelligence to fight antimicrobial resistance
Diagnostics gathering intelligence to fight antimicrobial resistance Arjon van Hengel European Commission DG Research and Innovation, Health Directorate Unit "Fighting Infectious Diseases and Advancing
More informationUBS Global Life Sciences Conference
September 20, 2011 UBS Global Life Sciences Conference Tecan Group AG Dr. Rudolf Eugster, CFO September 20, 2011 / p2 / UBS GLSC Contents Introducing Tecan Strategic Growth Drivers Financials H1 2011 &
More informationRoche, Roche Molecular Diagnostics and more
, Molecular and more [Monte Wetzel, PhD] Patients have questions. We provide answers. Group Clear focus on Healthcare Innovation with two strong pillars Pharma Pharma Genentech Chugai Molecular Professional
More informationUpdate on Pediatric diagnostics, EID and POC
UNICEF / Supply Division Health Technology Centre (HTC) Medical Unit Update on Pediatric diagnostics, EID and POC Ludo Scheerlinck Technical Officer, Medical Devices & Clinical Laboratory UNICEF Supply
More informationOLED/OPD transducer for point-of-use diagnostics
OLED/OPD transducer for point-of-use diagnostics Overview 1. CDT overview + Biosensor platform overview CDT overview Absorbance based lateral flow device (LFD) basics and advantages Abingdon Health collaboration
More informationA handheld system for DNA test based on Lab on chip technologies. Marco Bianchessi
A handheld system for DNA test based on Lab on chip technologies Marco Bianchessi History 2 Mid 90s: Lab on chip introduction From niche to high-volumes products What is needed: 3 Miniaturization 75 000
More informationUBS Global Life Sciences Conference
September 21, 2010 UBS Global Life Sciences Conference Tecan Group AG Thomas Bachmann, CEO September 21, 2010 / p2 / UBS Global Life Sciences Conference Introducing Tecan Provider of instruments and workflow-solutions
More informationUF Center for Pharmacogenomics. Explanation of Services. UF Center for Pharmacogenomics Services
UF Center for Pharmacogenomics Explanation of Services Services are provided either as a price per sample or price per project, depending on the specific needs of the researcher. Basic a la carte services,
More informationHerpes Simplex Virus Type 1 (HSV-1) IgM ELISA Kit Protocol
Herpes Simplex Virus Type 1 (HSV-1) IgM ELISA Kit Protocol (Cat. No.:EK-310-93) 330 Beach Road, Burlingame CA Tel: 650-558-8898 Fax: 650-558-1686 E-Mail: info@phoenixpeptide.com www.phoenixpeptide.com
More informationAll your genetic analyses on a single instrument
GENOMELAB GEXP GENETIC ANALYSIS SYSTEM All your genetic analyses on a single instrument GENOMELAB GEXP GENETIC ANALYSIS SYSTEM All on a single instrument Perform your genetic assays on one instrument A
More informationTaqPath ProAmp Master Mixes
PRODUCT BULLETIN es es Applied Biosystems TaqPath ProAmp Master Mixes are versatile master mixes developed for high-throughput genotyping and copy number variation (CNV) analysis protocols that require
More informationQIAGEN Sample & Assay Technologies From Discovery to Patient
QIAGEN From Discovery to Patient New York, February 14 QIAGEN 2008 Analyst & Investor Day Peer Schatz, CEO -7- Forward Looking Statements Safe Harbor Statement: Certain of the statements contained in this
More informationImproving the Limit of Detection of Lateral Flow Assays using 3DNA Technology
Improving the Limit of Detection of Lateral Flow Assays using 3DNA Technology Introduction Lateral Flow (LF) and similar assays represent a unique growing class of Point of Care (POC) tests designed to
More informationIntroductie en Toepassingen van Next-Generation Sequencing in de Klinische Virologie. Sander van Boheemen Medical Microbiology
Introductie en Toepassingen van Next-Generation Sequencing in de Klinische Virologie Sander van Boheemen Medical Microbiology Next-generation sequencing Next-generation sequencing (NGS), also known as
More informationOctober 29 - November
Les Pensières Veyrier-du-Lac (French Alps) October 29 - November 3 2017 Organized by The Mérieux Foundation and the London School of Hygiene & Tropical Medicine ACDx enhances the knowledge and professional
More informationQIAGEN Whole Genome Amplification REPLI-g Eliminating Sample Limitations, Potential Use for Reference Material
QIAGEN Whole Genome Amplification REPLI-g Eliminating Sample Limitations, Potential Use for Reference Material MDA Technology Protocols Locus Bias Applications Kits & Service Summary QIAGEN REPLI-g WGA
More informationInterpretation of Results. Jan Pedersen USDA, APHIS, VS, National Veterinary Services Laboratories, Ames, IA 50010
Interpretation of Results Jan Pedersen USDA, APHIS, VS, National Veterinary Services Laboratories, Ames, IA 50010 Instrumentation Cepheid Smartcycler Training Diagnostic testing Equivalency testing for
More informationAmerican Society of Cytopathology Core Curriculum in Molecular Biology
American Society of Cytopathology Core Curriculum in Molecular Biology American Society of Cytopathology Core Curriculum in Molecular Biology Chapter 4 Stephanie A. Hamilton, EdD, SCT, MB(ASCP) CM MD Anderson
More informationRealStar Filovirus Type RT-PCR Kit /2014
RealStar Filovirus Type RT-PCR Kit 1.0 08/2014 RealStar Filovirus Type RT-PCR Kit 1.0 For research use only! (RUO) Product No.: 451003 96 rxns Store at -25 C... -15 C INS-451000-EN-02 August 2014 altona
More information1001 NW Technology Drive, Lee's Summit, MO // (800) // (816) Fax //
Herpes Simplex Virus 1 & 2 (HSV-1 & HSV-2) Quantitative Real-time PCR Test Code: 8500 Some specimen types for this assay are reported as qualitative results; please see our Specimen Information section
More informationaltona altona RealStar Filovirus Screen RT-PCR Kit 1.0 always a drop ahead. 05/2014 altona Diagnostics GmbH Mörkenstr Hamburg Germany
altona DIAGNOSTICS altona DIAGNOSTICS RealStar Filovirus Screen RT-PCR Kit 1.0 05/2014 altona Diagnostics GmbH Mörkenstr. 12 22767 Hamburg Germany phone +49 40 548 06 76-0 fax +49 40 548 06 76-10 e-mail
More informationEpigenetic CHaracterization and Observation (ECHO) Proposers Day
Epigenetic CHaracterization and Observation (ECHO) Proposers Day Eric Van Gieson, Ph.D. Program Manager Biological Technologies Office (BTO) February 23, 2018 ECHO Program Overview Determining Exposure
More informationThe In Vitro Diagnostic CRO
The In Vitro Diagnostic CRO Choose Beaufort Because of Our People, Processes and Proven Experience The value of expertise cannot be overstated, especially when it comes to streamlining complicated in vitro
More informationPCR SYSTEMS. a new era in high-productivity qpcr. Applied Biosystems ViiA 7 Real-Time PCR System
PCR SYSTEMS a new era in high-productivity qpcr Applied Biosystems ViiA 7 Real-Time PCR System a new era in high-productivity qpcr The ViiA 7 Real-Time PCR System delivers the proven reliability, sensitivity,
More informationLecture #1. Introduction to microarray technology
Lecture #1 Introduction to microarray technology Outline General purpose Microarray assay concept Basic microarray experimental process cdna/two channel arrays Oligonucleotide arrays Exon arrays Comparing
More informationInstructions for Use. RealStar Filovirus Screen RT-PCR Kit /2017 EN
Instructions for Use RealStar Filovirus Screen RT-PCR Kit 1.0 01/2017 EN RealStar Filovirus Screen RT-PCR Kit 1.0 For use with Mx 3005P QPCR System (Stratagene) VERSANT kpcr Molecular System AD (Siemens
More informationSNP GENOTYPING WITH iplex REAGENTS AND THE MASSARRAY SYSTEM
SNP GENOTYPING Accurate, sensitive, flexible MassARRAY System SNP GENOTYPING WITH iplex REAGENTS AND THE MASSARRAY SYSTEM Biomarker validation Routine genetic testing Somatic mutation profiling Up to 400
More informationBioinformatics and computational tools
Bioinformatics and computational tools Etienne P. de Villiers (PhD) International Livestock Research Institute Nairobi, Kenya International Livestock Research Institute Nairobi, Kenya ILRI works at the
More informationBiosafety and the NIH Guidelines
Biosafety and the NIH Guidelines This section will explore: Why the NIH Guidelines are important The definition of recombinant or synthetic nucleic acid research Content of the NIH Guidelines Section III
More informationReflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug development
1 2 3 24 June 2010 EMA/CHMP/641298/2008 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 7 Reflection paper on co-development of pharmacogenomic biomarkers and Assays in the context of drug
More informationGLOBAL DIAGNOSTICS 1
GLOBAL DIAGNOSTICS 1 Features Accurate Extended shelf-life Room temperature storage Affordable Flexible Simple Rapid results Benefits Highly sensitive and specific results, delivered through proven technology
More informationAmpliSens HCV-1/2/3-FRT
For Professional Use Only AmpliSens HCV-1/2/3-FRT PCR kit Instruction Manual AmpliSens Federal Budget Institute of Science Central Research Institute for Epidemiology 3A Novogireevskaya Street Moscow 111123
More informationFor personal use only
ASX ANNOUNCEMENT Non-Deal Roadshow Presentation 25 May 2015 Sydney, 25 May 2015: Genetic Signatures (ASX: GSS) is pleased to release a copy of the presentation that John Melki, PhD., Director & CEO and
More informationGuide to Shipping Biological Materials
Guide to Shipping Biological Materials Introduction This manual is to aid in the shipment of biological materials from Dartmouth College in compliance with the US Department of Transportation (DOT) and
More informationContext and objectives of the workshop on platform technologies. 21 July 2016 David Wood and Virginia Benassi
Context and objectives of the workshop on platform technologies 21 July 2016 David Wood and Virginia Benassi 2nd Technical workshop on platform technologies Geneva, Switzerland, 21 July 2016 Platform Technologies
More informationGenPlex HID Training Class I
Rixun Fang GenPlex HID Training Class I Outline of Presentation Introduction GenPlex HID kit Experimental plan Class schedule Forensic SNP Analysis GenPlex HID Training Class I 2 Potential Forensic Applications
More informationLATE-PCR. Linear-After-The-Exponential
LATE-PCR Linear-After-The-Exponential A Patented Invention of the Laboratory of Human Genetics and Reproductive Biology Lab. Director: Lawrence J. Wangh, Ph.D. Department of Biology, Brandeis University,
More informationMinimise risk. Maximise competitive edge.
Minimise risk. Maximise competitive edge. Innovative food and environmental safety solutions optimised for your unique needs It s time to put your pathogen testing to the test When the world s biggest
More informationSection I: Pharmaceuticals and Medical Devices
SUPPLEMENT on HEALTHCARE INNOVATION Visionary Goals and Recommendations 51th Japan-U.S. Business Conference Japan-U.S. Business Council / U.S.-Japan Business Council November 14, 2014 The R&D-based pharmaceutical
More informationFacilitating local production for improved access to in vitrodiagnostics. Tuberculosis. Ruth McNerney. Ruth McNerney & Rosanna Peeling
Tuberculosis Facilitating local production for improved access to in vitrodiagnostics Ruth McNerney & Rosanna Peeling Ruth McNerney London School of Hygiene & Tropical Medicine Department of Pathogen Molecular
More informationEbola: A latent threat to Latin America. Are we ready?
Ebola: A latent threat to Latin America. Are we ready? Item type Authors DOI Publisher Journal Rights info:eu-repo/semantics/article Rodríguez Morales, Alfonso J.; Henao, Daniel E.; Franco, Tulio B.; Mayta-Tristan,
More informationMicrobiome Analysis in Kawasaki Disease. Kristine M. Wylie, Susan C. Baker, George M. Weinstock, Stanford T. Shulman, and Anne H.
Microbiome Analysis in Kawasaki Disease Kristine M. Wylie, Susan C. Baker, George M. Weinstock, Stanford T. Shulman, and Anne H. Rowley Disclosures Kristine M. Wylie Microbiome Analysis in Kawasaki Disease
More informationPAREXEL GENOMIC MEDICINE SERVICES. Applying genomics to enhance your drug development journey
PAREXEL GENOMIC MEDICINE SERVICES Applying genomics to enhance your drug development journey YOUR JOURNEY. OUR MISSION. Genomic expertise to simplify the route to product approval and maximize patient
More informationAP Biology Reading Guide BI #3 Chapter 19: Viruses
AP Biology Reading Guide BI #3 Chapter 19: Viruses Concept 19.1 A virus consists of a nucleic acid surrounded by a protein coat 1. What was some early evidence of the existence of viruses? Why were they
More information35th Annual J.P. Morgan Healthcare Conference
35th Annual J.P. Morgan Healthcare Conference Investor Presentation Nachum Homi Shamir President and Chief Executive Officer January, 2017 Safe Harbor Statement Certain statements made during the course
More informationPERFORMANCE MADE EASY REAL-TIME PCR
PERFORMANCE MADE EASY REAL-TIME PCR The MyGo Pro real-time PCR instrument provides unmatched performance in a convenient format. Novel Full Spectrum Optics deliver 120 optical channels of fluorescence
More informationInstructions for Use. RealStar HEV RT-PCR Kit /2017 EN
Instructions for Use RealStar HEV RT-PCR Kit 2.0 07/2017 EN RealStar HEV RT-PCR Kit 2.0 For use with Mx 3005P QPCR System (Stratagene) VERSANT kpcr Molecular System AD (Siemens Healthcare) ABI Prism 7500
More informationThe need for mobile devices for rapid diagnosis of febrile or infectious diseases in resource-poor countries
Dept. Medical Parasitology and Infection Biology Molecular Parasitology-Epidemiology Unit The need for mobile devices for rapid diagnosis of febrile or infectious diseases in resource-poor countries 2016
More informationLife Sciences Online Courses
Life Sciences Online Courses Table Of Contents Table of Contents How to Register 3 Learn Biotechnology Online 4 Learn MedDevice Online 5 Learn Molecular Diagnostics Online 6 Learn Biosafety & Biorisk Online
More informationEXTRACTME Kits, Product Brochure
EXTRACTME Kits, Product Brochure Interest in any of the products, request or order them at Bio-Connect. Bio-Connect B.V. T NL +31 (0)26 326 44 50 T BE +32 (0)2 503 03 48 Begonialaan 3a F NL +31 (0)26 326
More informationDISASTER A total of 2,615 Ebola infections and 1,427 deaths highest case fatality rates of any human virus, 88%
DISASTER A total of 2,615 Ebola infections and 1,427 deaths highest case fatality rates of any human virus, 88% ETYMOLOGY First recorded outbreak at,yambuku in democratic republic of congo (EBOLA RIVER)
More informationTaKaRa MiniBEST Viral RNA/DNA Extraction Kit Ver.5.0
Cat. # 9766 For Research Use TaKaRa MiniBEST Viral RNA/DNA Extraction Kit Ver.5.0 Product Manual Table of Contents I. Description... 3 II. Components... 3 III. Storage and shipping... 3 IV. Preparation
More informationTECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT
Specialist in tissue analysis by Histology, Immunohistochemistry and In Situ Hybridization TECHNOLOGIES & SERVICES FOR THERAPEUTIC ANTIBODY DEVELOPMENT CONTENTS Histalim: who we are Our areas of expertise
More informationIon S5 and Ion S5 XL Systems
Ion S5 and Ion S5 XL Systems Targeted sequencing has never been simpler Explore the Ion S5 and Ion S5 XL Systems Adopting next-generation sequencing (NGS) in your lab is now simpler than ever The Ion S5
More informationDevelopment of diagnostic kits for selected markers of resistance, virulence and zoonotic transmission among methicillinresistant
Development of diagnostic kits for selected markers of resistance, virulence and zoonotic transmission among methicillinresistant Staphylococcus aureus strains Dr. Boris Oberheitmann, Constanze Seidel
More informationManagement of Ebola virus disease: is environmental decontamination effective?
Management of Ebola virus disease: is environmental decontamination effective? Short title: Clinical decontamination of Ebola virus Walker NF 1, Youkee D 2, Brown CS 3, Lado M 3, Johnson O 3. 1 Department
More informationZaire Ebola Virus. genesig Advanced Kit. Nucleoprotein (np) gene. 150 tests. Primerdesign Ltd. For general laboratory and research use only
TM Primerdesign Ltd Zaire Ebola Virus Nucleoprotein (np) gene genesig Advanced Kit 150 tests For general laboratory and research use only 1 Introduction to Zaire Ebola Virus Ebola viruses are the causative
More information! "! " # $ % & ' $ (!)* + * ",- '(!)* +. '/0 $ - 1 $
!"!" #$%& ' $ (!)*+*",-'(!)*+.'/0$- 1 $ + 234 1506417 5" 8/" (!)*+ 9 '(!)" 9 ' 9 '(!)*+* ' 9 1 / 1" '" 8' " '2 " 8',, 5+ 234 15064 17 5(!)"7, " 2 " '2 ' " 6 64 17 "," " " 64 1 "22 : " " " 641 2,0 '," )
More informationSANTA CRUZ BIOTECHNOLOGY, INC.
TECHNICAL SERVICE GUIDE: Western Blotting 2. What size bands were expected and what size bands were detected? 3. Was the blot blank or was a dark background or non-specific bands seen? 4. Did this same
More information